Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsIndia

Coronavirus | US State Department supports companies choosing India as alternative to China: Report

In a meeting between a senior official of the US Department of State and representatives of American companies, India's importance as a potential business destination was noted.

April 29, 2020 / 03:43 PM IST

The US Department of State supports the idea that India may become an alternative investment destination for American companies after businesses move out of China due to the novel coronavirus, or COVID-19, pandemic.

In a meeting last week between a senior official of the US Department of State and representatives of American companies, India's importance as a potential business destination was noted, The Economic Times reported.

To track all live updates from the coronavirus pandemic, click here

"India can quickly become a favourable jurisdiction for more of the industrial activities that are happening currently in China," Thomas Vajda, Assistant Secretary of State for South Asia in the US Department of State, said during a video conference.

Moneycontrol could not independently verify the report.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

At the meeting, it was suggested that US-based companies request the Indian government to provide incentives to boost investment by American firms, the report stated.

"Government relations between the two countries will be supportive," Vajda said, as quoted by the publication.

Follow our full coverage of the coronavirus pandemic here.
Moneycontrol News
first published: Apr 29, 2020 03:43 pm
ISO 27001 - BSI Assurance Mark